Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
Leiden University Medical Center
500 participants
Mar 5, 2019
OBSERVATIONAL
Conditions
Summary
PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.
Eligibility
Inclusion Criteria4
- Age ≥18 years
- Clinical or pathological diagnosis of a melanoma of the choroid or ciliary body
- No signs of metastasis after staging procedures with at least an X-thorax, blood test and an ultrasound of the liver
- Treatment by brachytherapy, proton therapy or enucleation
Exclusion Criteria1
- None
Interventions
Collection of patient-reported outcomes concerning general and health-related quality of life and impact of uveal melanoma diagnosis
Assessment of patient preferences for outcomes of proton therapy and enucleation
Assessment of shared decision-making from the perspective of the patient (by questionnaire), physician (by questionnaire) and a neutral observer (by audiotape), combined with patient-reported satisfaction and regret of the treatment decision (by questionnaire)
Assessment of the impact of side-effects by questionnaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05377957